AFC
DXCM icon

AFT Forsyth & Company’s DexCom DXCM Stock Holding History

AFT Forsyth & Company’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,415
Closed -$387K – 129
2024
Q3 		$387K Hold
3,415
– – 0.19% 98
2024
Q2 		$387K Buy
3,415
+275
+9% +$34.8K 0.19% 99
2024
Q1 		$436K Sell
3,140
-690
-18% -$86.7K 0.25% 91
2023
Q4 		$475K Sell
3,830
-995
-21% -$102K 0.3% 83
2023
Q3 		$450K Sell
4,825
-225
-4% -$25.4K 0.33% 77
2023
Q2 		$649K Sell
5,050
-3,985
-44% -$482K 0.46% 61
2023
Q1 		$1.05M Sell
9,035
-75
-0.8% -$8.39K 0.81% 34
2022
Q4 		$1.03M Buy
9,110
+2,890
+46% +$317K 0.88% 32
2022
Q3 		$501K Hold
6,220
– – 0.45% 68
2022
Q2 		$464K Sell
6,220
-1,440
-19% -$131K 0.37% 79
2022
Q1 		$980K Sell
7,660
-4,520
-37% -$494K 0.62% 45
2021
Q4 		$1.64M Hold
12,180
– – 0.84% 32
2021
Q3 		$1.67M Sell
12,180
-120
-1% -$15.1K 0.89% 30
2021
Q2 		$1.31M Sell
12,300
-300
-2% -$28.8K 0.7% 42
2021
Q1 		$1.13M Hold
12,600
– – 0.68% 43
2020
Q4 		$1.17M Buy
12,600
+1,200
+11% +$107K 0.73% 38
2020
Q3 		$1.18M Hold
11,400
– – 0.87% 31
2020
Q2 		$1.16M Sell
11,400
-100
-0.9% -$8.95K 0.97% 29
2020
Q1 		$774K Buy
+11,500
New +$716K 0.78% 42

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AFT Forsyth & Company's DXCM Position: Q4 2024 in Review

AFT Forsyth & Company sold out of DexCom (DXCM) in Q4 2024, closing a stake of 3,415 shares — an estimated $387K sold.

AFT Forsyth & Company first reported a position in DXCM in Q1 2020 and held it in 19 quarters. The position peaked at $1.67M in Q3 2021. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • AFT Forsyth & Company reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • AFT Forsyth & Company sold 3,415 DexCom shares in Q4 2024, an estimated $387K.
  • AFT Forsyth & Company first reported a position in DexCom in Q1 2020 and held it in 19 quarters.
  • AFT Forsyth & Company's DexCom position peaked at $1.67M in Q3 2021.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on AFT Forsyth & Company's 13F filing for Q4 2024, filed 29 Jan 2025.